These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 24767108)
61. Nitric oxide: Antidepressant mechanisms and inflammation. Ghasemi M Adv Pharmacol; 2019; 86():121-152. PubMed ID: 31378250 [TBL] [Abstract][Full Text] [Related]
62. Plasma dehydroepiandrosterone sulfate levels in patients with major depressive disorder correlate with remission during treatment with antidepressants. Morita T; Senzaki K; Ishihara R; Umeda K; Iwata N; Nagai T; Hida H; Nabeshima T; Yukawa K; Ozaki N; Noda Y Hum Psychopharmacol; 2014 May; 29(3):280-6. PubMed ID: 24911578 [TBL] [Abstract][Full Text] [Related]
63. Relationship of asymmetrical dimethylarginine, nitric oxide, and sustained attention during attack in patients with major depressive disorder. Canpolat S; Kırpınar I; Deveci E; Aksoy H; Bayraktutan Z; Eren I; Demir R; Selek S; Aydın N ScientificWorldJournal; 2014; 2014():624395. PubMed ID: 24558318 [TBL] [Abstract][Full Text] [Related]
64. Serotonin and amino acid content in platelets of autistic children. Rolf LH; Haarmann FY; Grotemeyer KH; Kehrer H Acta Psychiatr Scand; 1993 May; 87(5):312-6. PubMed ID: 8517170 [TBL] [Abstract][Full Text] [Related]
65. Plasma L-tryptophan concentration in major depressive disorder: new data and meta-analysis. Ogawa S; Fujii T; Koga N; Hori H; Teraishi T; Hattori K; Noda T; Higuchi T; Motohashi N; Kunugi H J Clin Psychiatry; 2014 Sep; 75(9):e906-15. PubMed ID: 25295433 [TBL] [Abstract][Full Text] [Related]
66. Plasma fibrinogen: now also an antidepressant response marker? Martins-de-Souza D; Maccarrone G; Ising M; Kloiber S; Lucae S; Holsboer F; Turck CW Transl Psychiatry; 2014 Jan; 4(1):e352. PubMed ID: 24473443 [TBL] [Abstract][Full Text] [Related]
67. Plasma omega-3 polyunsaturated fatty acids and survival in patients with chronic heart failure and major depressive disorder. Jiang W; Oken H; Fiuzat M; Shaw LK; Martsberger C; Kuchibhatla M; Kaddurah-Daouk R; Steffens DC; Baillie R; Cuffe M; Krishnan R; O'Connor C; J Cardiovasc Transl Res; 2012 Feb; 5(1):92-9. PubMed ID: 22042636 [TBL] [Abstract][Full Text] [Related]
68. ErbB3 mRNA leukocyte levels as a biomarker for major depressive disorder. Milanesi E; Minelli A; Cattane N; Cattaneo A; Mora C; Barbon A; Mallei A; Popoli M; Florio V; Conca A; Bignotti S; Gennarelli M BMC Psychiatry; 2012 Sep; 12():145. PubMed ID: 22989054 [TBL] [Abstract][Full Text] [Related]
69. Development of psychopathology in deployed armed forces in relation to plasma GABA levels. Schür RR; Boks MP; Geuze E; Prinsen HC; Verhoeven-Duif NM; Joëls M; Kahn RS; Vermetten E; Vinkers CH Psychoneuroendocrinology; 2016 Nov; 73():263-270. PubMed ID: 27566489 [TBL] [Abstract][Full Text] [Related]
70. Effects of long-term antidepressant treatment on oxidative status in major depressive disorder: a 24-week follow-up study. Kotan VO; Sarandol E; Kirhan E; Ozkaya G; Kirli S Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jul; 35(5):1284-90. PubMed ID: 21515329 [TBL] [Abstract][Full Text] [Related]
71. A study of intensity dependence of the auditory evoked potential (IDAEP) in medicated melancholic and non-melancholic depression. Fitzgerald PB; Mellow TB; Hoy KE; Segrave R; Cooper NR; Upton DJ; Croft RJ J Affect Disord; 2009 Oct; 117(3):212-6. PubMed ID: 19201033 [TBL] [Abstract][Full Text] [Related]
72. Co-morbidity and stability of melancholic features in DSM-IV major depressive disorder. Melartin T; Leskelä U; Rytsälä H; Sokero P; Lestelä-Mielonen P; Isometsä E Psychol Med; 2004 Nov; 34(8):1443-52. PubMed ID: 15724875 [TBL] [Abstract][Full Text] [Related]
73. Cerebrospinal fluid levels of glutamate and corticotropin releasing hormone in major depression before and after treatment. Garakani A; Martinez JM; Yehuda R; Gorman JM J Affect Disord; 2013 Apr; 146(2):262-5. PubMed ID: 22840611 [TBL] [Abstract][Full Text] [Related]
74. BDNF as a biomarker for successful treatment of mood disorders: a systematic & quantitative meta-analysis. Polyakova M; Stuke K; Schuemberg K; Mueller K; Schoenknecht P; Schroeter ML J Affect Disord; 2015 Mar; 174():432-40. PubMed ID: 25553404 [TBL] [Abstract][Full Text] [Related]
75. High-affinity transport of gamma-aminobutyric acid, glycine, taurine, L-aspartic acid, and L-glutamic acid in synaptosomal (P2) tissue: a kinetic and substrate specificity analysis. Debler EA; Lajtha A J Neurochem; 1987 Jun; 48(6):1851-6. PubMed ID: 2883259 [TBL] [Abstract][Full Text] [Related]
76. Amino acids acting as transmitters in amyotrophic lateral sclerosis (ALS). Niebroj-Dobosz I; Janik P Acta Neurol Scand; 1999 Jul; 100(1):6-11. PubMed ID: 10416506 [TBL] [Abstract][Full Text] [Related]
77. S-100B is increased in melancholic but not in non-melancholic major depression. Rothermundt M; Arolt V; Wiesmann M; Missler U; Peters M; Rudolf S; Kirchner H J Affect Disord; 2001 Sep; 66(1):89-93. PubMed ID: 11532538 [TBL] [Abstract][Full Text] [Related]
78. Demographic and clinical features and prescribing patterns of psychotropic medications in patients with the melancholic subtype of major depressive disorder in China. Xiang YT; Wang G; Hu C; Guo T; Ungvari GS; Kilbourne AM; Lai KY; Si TM; Zheng QW; Chen DF; Fang YR; Lu Z; Yang HC; Hu J; Chen ZY; Huang Y; Sun J; Wang XP; Li HC; Zhang JB; Chiu HF PLoS One; 2012; 7(6):e39840. PubMed ID: 22768140 [TBL] [Abstract][Full Text] [Related]
79. The inflammatory marker GDF-15 is not independently associated with late-life depression. Teunissen CE; Durieux-Lu S; Blankenstein MA; Oude Voshaar RC; Comijs HC J Psychosom Res; 2016 Apr; 83():46-9. PubMed ID: 27020076 [TBL] [Abstract][Full Text] [Related]